ArticleScientific reports2026
Unmasking inequalities in gastrointestinal cancer outcomes among Asian American subpopulations.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, gastrointestinal (GI) cancer burden is higher in Asian populations. Asian Americans are commonly aggregated into a single category, potentially masking disparities. This study compared mortality from GI cancers among Asian American subpopulations to White patients. Mortality data (2018–2023) was collected from Centers for Disease Control Wide-ranging Online Data for Epidemiologic Research which included White and Asian subgroups: Indian Americans, Chinese, Filipino, Japanese, Korean, and Vietnamese. Deaths from all causes and GI cancers (esophagus, stomach, small intestine, colon, rectal, anal, hepatobiliary, and pancreas) were analyzed. Proportional mortality (PM) was calculated as cancer deaths divided by all deaths. During the study period, there were 425,162 total deaths and 34,167 deaths from GI cancers among the Asian American population in the United states, compared to 14,066,027 total deaths and 713,638 deaths from GI cancers among the White population (PM 8.0% vs. 5.1%, p < 0.001). Among Asian American women, the largest disparities in PM were observed in patients with stomach (1.0% vs. 0.2%, p < 0.001) and hepatobiliary cancers (1.7% vs. 0.7%), p < 0.001) relative to White women. Similarly, among Asian American men, the largest disparities were also observed in stomach (1.1% vs. 0.3%, p < 0.001) and hepatobiliary cancers (2.7% vs. 1.1%, p < 0.001). Anal cancers was the only GI cancer for which Asian American women (0.02% vs. 0.07%) and men (0.02% vs. 0.04%) had lower PMs compared to the White population. Asian Americans experience greater mortality from GI cancers compared to white patients. The largest differences in PM were observed in stomach and hepatobiliary cancers across both male and female populations and all age categories. Culturally competent strategies that tailor screening guidelines and cancer prevention efforts to the unique risk profiles of Asian American subpopulations are desperately needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.